Advertisement

Topics

Ultivue Inc. Company Profile

05:21 EDT 27th June 2019 | BioPortfolio

Founded by world-leading experts in biomolecular analysis, Ultivue is a venture-backed company developing reagent-driven solutions for high-definition biological imaging in situ, combining unlimited multiplexing at high speed with high spatial resolution. Ultivue’s proprietary reagents, instruments, and bioinformatics tools will enable researchers and clinicians to realize the promise of personalized medicine through better matching of patients to therapeutic options. In 2017, the company is launching products and services that seamlessly integrate into existing workflows for biomarker discovery, assay validation, and companion diagnostic applications. Ultivue is based in Cambridge, MA.


News Articles [5 Associated News Articles listed on BioPortfolio]

Ultivue Expands UltiMapper™ Platform of Multiplex Assays for Tissue Immuno-Profiling

Ultivue, a developer of tissue biomarker identification and quantification assays for translational research and pathology labs, today announced two new additions to its existing ...

Ultivue Expands Global Presence with Opening of European Subsidiary, Ultivue EMEA Srl

Ultivue, a developer of tissue biomarker identification and quantification assays for pathology and translational research labs, today announced that it has expanded its commercia...

Ultivue releases breakthrough innovations for multiplex IHC: 16-marker whole-slide visualization and high marker co-localization in FFPE tissue

Ultivue today unveiled the expanded capabilities of its proprietary InSituPlex® DNA-barcoding and staining technology through comprehensive visualization of a whole slide 16-mark...

Definiens and Ultivue Announce a Collaboration to Co-Develop Joint Offerings in Multiplexed Immunofluorescence (IF) and AI Enabled Digital Image Analysis

Ultivue, a developer of tissue biomarker identification and quantification assays for translational and pathology research labs, and Definiens, a pioneer in artificial intelligenc...

Ultivue Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 27092018] Prices from USD $250

SummaryUltivue Inc Ultivue is a life sciences company that concentrates on developing tools for imaging. The company manufactures reagents that enable researchers to obtain microscopic images with muc...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [1 Associated Companies listed on BioPortfolio]

Ultivue Inc.

Founded by world-leading experts in biomolecular analysis, Ultivue is a venture-backed company developing reagent-driven solutions for high-definition biological imaging in situ, ...

More Information about "Ultivue Inc." on BioPortfolio

We have published hundreds of Ultivue Inc. news stories on BioPortfolio along with dozens of Ultivue Inc. Clinical Trials and PubMed Articles about Ultivue Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Ultivue Inc. Companies in our database. You can also find out about relevant Ultivue Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...

Assays
An assay is an analytic procedure for qualitatively assessing or quantitatively measuring the presence or amount or the functional activity of a target entity.  This can be a drug or biochemical substance or a cell in an organism or organic sample. ...


Corporate Database Quicklinks



Searches Linking to this Company Record